Fineline Cube

Follow:
14475 Articles
CompanyDeals

Innovent Biologics Plans Share Placement to Raise HKD 2.36 Billion for Global Expansion

Policy / Regulatory

NMPA Pilots Priority Review for Rare Disease Formula Foods, Aims to Reduce Approval Time

CompanyMedical Device

Huadong Medicine’s Subsidiary Viora Ltd’s V20 Accepted for NMPA Review

CompanyDrug

Gan & Lee Pharmaceuticals Initiates Phase II Clinical Study for Weekly Insulin GZR4

CompanyDrug

Grand Pharmaceutical Receives NMPA Approval for Generic Carbaglu for Hyperammonemia Treatment

CompanyDeals

JW Therapeutics and 2seventy Bio Expand Partnership for Cell Therapy Development

CompanyDeals

Wuhan YZY Biopharma Aims to Raise HKD 220 Million in Hong Kong IPO

CompanyDeals

Exelixis Secures Global Rights to Develop Insilico Medicine’s USP1 Inhibitor ISM3091

CompanyMedical Device

Burning Rock’s CanCatch MRD Product Shows Superiority in Postoperative NSCLC Monitoring

CompanyDrug

Clover Biopharmaceuticals Launches AdimFlu-S, the Only Imported Quadrivalent Influenza Vaccine in China

CompanyDrug

HutchMed Advances Tazverik Phase II Trial for Follicular Lymphoma in China

CompanyDrug

Hybio Pharmaceutical’s Semaglutide Clinical Trial Filing Accepted by China’s NMPA